Alpha 2.0
Login Register
» Authors » Eloisi C Lopes

Eloisi C Lopes

Explore the profile of Eloisi C Lopes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 186
Followers 0
Related Specialties
General Medicine
Oncology
Molecular Biology
Top 10 Co-Authors
Silvia E Hajos
Ari Melnick
Elida Alvarez
Gabriela Chiosis
Jennifer Walling
Lyuba Varticovski
Alka Mallik
Rita Shaknovich
Karen L Bunting
Lucas A Tsikitas
Published In
Nat Med
Leuk Res
Clin Exp Metastasis
Cancer Res
Affiliations
Soon will be listed here.
Recent Articles
1.
Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
Cerchietti L, Lopes E, Yang S, Hatzi K, Bunting K, Tsikitas L, et al.
Nat Med . 2024 Apr; 30(5):1503. PMID: 38570701
No abstract available.
2.
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas
Cerchietti L, Lopes E, Yang S, Hatzi K, Bunting K, Tsikitas L, et al.
Nat Med . 2009 Dec; 15(12):1369-76. PMID: 19966776
We report that heat shock protein 90 (Hsp90) inhibitors selectively kill diffuse large B cell lymphomas (DLBCLs) that depend on the BCL-6 transcriptional repressor. We found that endogenous Hsp90 interacts...
3.
Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines
Lopes E, Valls E, Figueroa M, Mazur A, Meng F, Chiosis G, et al.
Cancer Res . 2008 Sep; 68(18):7258-63. PMID: 18794111
Aberrant CpG methylation of tumor suppressor gene regulatory elements is associated with transcriptional silencing and contributes to malignant transformation of different tissues. It is presumed that methylated DNA sequences recruit...
4.
Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines
Garcia M, Alaniz L, Lopes E, Blanco G, Hajos S, Alvarez E
Leuk Res . 2005 Jun; 29(12):1425-34. PMID: 15982733
Multidrug resistance (MDR) is the main reason for failure of cancer therapy with resistance to apoptosis being one of the mechanisms involved. Constitutive NF-kappaB activity has been detected in many...
5.
Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype
Lopes E, Garcia M, Benavides F, Shen J, Conti C, Alvarez E, et al.
Leuk Res . 2003 Mar; 27(5):413-23. PMID: 12620293
Among the mechanisms that induce multidrug resistance (MDR), one of those most frequent is over-expression of a phosphoglycoprotein (Pgp) encoded in the mouse by the mdr-1 and mdr-3 genes. We...
6.
Dissimilar invasive and metastatic behavior of vincristine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia
Lopes E, Ernst G, Aulicino P, Vanzulli S, Garcia M, Alvarez E, et al.
Clin Exp Metastasis . 2002 Jul; 19(4):283-90. PMID: 12090468
Multidrug resistance (MDR) lines from a murine T-cell lymphoid leukemia were selected in increasing vincristine (VCR) or doxorubicin (DOX) concentrations. Surface markers were determined by flow cytometry in both resistant...